Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.
Export 31 results:
Συντάκτης Τίτλος Τύπος [ Έτος] Φίλτρα: Συντάκτης is Fountzilas, G [Clear All Filters]
High prevalence of BRCA1 founder mutations in Greek breast/ovarian families..
Clin Genet. 85(1), 36-42.
(2014). The impact of oxaliplatin-based chemotherapy for colorectal cancer on the autonomous nervous system..
Eur J Neurol. 21(12), 1471-7.
(2014). Mutational profiling of the RAS, PI3K, MET and b-catenin pathways in cancer of unknown primary: a retrospective study of the Hellenic Cooperative Oncology Group..
Clin Exp Metastasis. 31(7), 761-9.
(2014). Vascular endothelial growth factor polymorphisms and clinical outcome in patients with metastatic breast cancer treated with weekly docetaxel..
Pharmacogenomics J. 14(3), 248-55.
(2014). Cyclin D1, EGFR, and Akt/mTOR pathway. Potential prognostic markers in localized laryngeal squamous cell carcinoma..
Strahlenther Onkol. 189(3), 202-14.
(2013). Development and validation of a prognostic model in patients with metastatic renal cell carcinoma treated with sunitinib: a European collaboration..
Br J Cancer. 109(2), 332-41.
(2013). HER2 gene copy number status may influence clinical efficacy to anti-EGFR monoclonal antibodies in metastatic colorectal cancer patients..
Br J Cancer. 108(3), 668-75.
(2013). Molecular profile of head and neck squamous cell carcinomas bearing p16 high phenotype..
Ann Oncol. 24(8), 2124-31.
(2013).
(2013).
(2013). Identification and validation of gene expression models that predict clinical outcome in patients with early-stage laryngeal cancer..
Ann Oncol. 23(8), 2146-53.
(2012). Prognostic significance of UBE2C mRNA expression in high-risk early breast cancer. A Hellenic Cooperative Oncology Group (HeCOG) Study..
Ann Oncol. 23(6), 1422-7.
(2012). Prognostic utility of angiogenesis and hypoxia effectors in patients with operable squamous cell cancer of the larynx..
Oral Oncol. 48(8), 709-16.
(2012).
(2012).
(2012). Evaluation of the association of PIK3CA mutations and PTEN loss with efficacy of trastuzumab therapy in metastatic breast cancer..
Breast Cancer Res Treat. 128(2), 447-56.
(2011).
(2011). Combination of osteopontin and activated leukocyte cell adhesion molecule as potent prognostic discriminators in HER2- and ER-negative breast cancer..
Br J Cancer. 103(7), 1048-56.
(2010). Fifteen-year trends in metastatic breast cancer survival in Greece..
Breast Cancer Res Treat. 119(3), 621-31.
(2010). A randomized phase III study of adjuvant platinum/docetaxel chemotherapy with or without radiation therapy in patients with gastric cancer..
Cancer Chemother Pharmacol. 65(6), 1009-21.
(2010).
(2010). Analysis of 7 immunohistochemical markers in male germ cell tumors demonstrates the prognostic significance of p53 and MIB-1..
Anticancer Res. 29(2), 737-44.
(2009). Contribution of BRCA1 germ-line mutations to breast cancer in Greece: a hospital-based study of 987 unselected breast cancer cases..
Br J Cancer. 101(1), 32-7.
(2009). Economic evaluation of taxane-based first-line chemotherapy in the treatment of patients with metastatic breast cancer in Greece: an analysis alongside a multicenter, randomized phase III clinical trial..
Ann Oncol. 20(2), 278-85.
(2009). Effects of epoetin-alpha on quality of life of cancer patients with solid tumors receiving chemotherapy..
Anticancer Res. 29(2), 693-702.
(2009).